ConductScience.org, home

Paper24314899

Ondansetron and the risk of cardiac arrhythmias: a systematic review and postmarketing analysis.

Freedman SB and 3 others. Ann Emerg Med, 2014. Cited by 93 papers, by iCite.

Cite this record

ConductScience Library. Ondansetron and the risk of cardiac arrhythmias: a systematic review and postmarketing analysis. Papers, record 24314899. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24314899

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ondansetron and the risk of cardiac arrhythmias: a systematic review and postmarketing analysis.
PubMed
Journal
Ann Emerg Med
PubMed
Year
2014
PubMed
Publication types
Journal Article, Systematic Review
PubMed
Citations, by iCite
93
iCite
Relative citation ratio, by iCite
4.06
iCite
Revised in PubMed
2025-07-11
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Freedman SBStephen B
2Uleryk EElizabeth
3Rumantir MMaggie
4Finkelstein YYaron

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntiemeticsMajor topic
Arrhythmias, CardiacMajor topic
OndansetronMajor topic
Product Surveillance, PostmarketingMajor topic
Emergency Treatment
Humans
Monitoring, Physiologic
Risk

Source PubMed

Download CSV of topics

Cited by42

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 93 citations.

PMIDTitleJournalYearIn PapersSource
42818164A Computational Model of Oxidative Stress in a Human Ventricular Myocyte.bioRxiv2026https://conductscience.org/library/papers/42818164PubMed
42748473Antiemetic-associated QT prolongation: a clinical review and risk-stratified prescribing framework for long QT syndrome.Eur Heart J Cardiovasc Pharmacother2026https://conductscience.org/library/papers/42748473PubMed
42473072Oral food challenges in FPIES: A narrative review and proposals for emergency and home-based management of acute FPIES reaction.Pediatr Allergy Immunol2026https://conductscience.org/library/papers/42473072PubMed
41800097QT-related adverse events with ondansetron and olanzapine: a real-world FAERS analysis with implications for oncology anti-emetic practice.Front Pharmacol2026https://conductscience.org/library/papers/41800097PubMed
41472511Major Adverse Cardiac Events with Ondansetron: A Systematic Review.Clin Pharmacol Ther2026https://conductscience.org/library/papers/41472511PubMed
41408751Arrhythmia risk predictions from molecular simulations of cardiac ion channel-drug interactions.Biophys J2026https://conductscience.org/library/papers/41408751PubMed
41293240The correlation between the use of ondansetron and mortality in sepsis associated encephalopathy patients: a retrospective ICU cohort study.Front Pharmacol2025https://conductscience.org/library/papers/41293240PubMed
41210447Ondansetron-induced cardiac arrest and cardiomyopathy with successful reversal: a case report.AME Case Rep2025https://conductscience.org/library/papers/41210447PubMed
41040275Prediction of TdP Arrhythmia Risk Through Molecular Simulations of Conformation-specific Drug Interactions with the hERG K+, Nav1.5, and Cav1.2 Channels.bioRxiv2025https://conductscience.org/library/papers/41040275PubMed
40856942Morbidity and Mortality of Ondansetron in Patients with Non-congenital Long QT Syndrome: A Review Article.Cardiovasc Drugs Ther2026https://conductscience.org/library/papers/40856942PubMed
40725767Inhaling Peppermint Essential Oil as a Promising Complementary Therapy in the Treatment of Nausea and Vomiting.J Clin Med2025https://conductscience.org/library/papers/40725767PubMed
38882995Prevalence, Attributes, and Risk Factors of QT-Interval-Prolonging Drugs and Potential Drug-Drug Interactions in Cancer Patients: A Prospective Study in a Tertiary Care Hospital.Cureus2024https://conductscience.org/library/papers/38882995PubMed
38566008Single intravenous dose ondansetron induces QT prolongation in adult emergency department patients: a prospective observational study.Int J Emerg Med2024https://conductscience.org/library/papers/38566008PubMed
38380631Understanding Australian Pharmacists' Perceptions on the Utilisation of Oral 5-HT3 Antagonists as Pharmacist-Only Anti-Emetics in Comparison to Oral D2 Antagonists.J Pharm Pract2024https://conductscience.org/library/papers/38380631PubMed
38179420Effects of ondansetron exposure during ICU stay on outcomes of critically ill patients with sepsis: a cohort study.Front Cell Infect Microbiol2023https://conductscience.org/library/papers/38179420PubMed
37936910Efficacy and safety of ondansetron for morning sickness in pregnancy: a systematic review of clinical trials.Front Pharmacol2023https://conductscience.org/library/papers/37936910PubMed
37680391Evaluation of cardiac indices using M-mode echocardiography after administration of metoclopramide and ondansetron in donkeys (Equus asinus): an experimental study.Front Vet Sci2023https://conductscience.org/library/papers/37680391PubMed
36110896Management of Chronic Migraine in Children and Adolescents: Where are We in 2022?Pediatric Health Med Ther2022https://conductscience.org/library/papers/36110896PubMed
35784927Early Postoperative Ondansetron Exposure is Associated with Reduced 90-Day Mortality in Patients Undergoing Cardiac Surgery.Front Surg2022https://conductscience.org/library/papers/35784927PubMed
35666723Clinical practice guideline of the Interamerican Society of Cardiology on primary prevention of cardiovascular disease in women.Arch Cardiol Mex2022https://conductscience.org/library/papers/35666723PubMed

See all 42 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24314899

GET https://conductscience.org/api/papers/v1/24314899/cited_by?page=2